National Heart, Lung, and Blood Institute (NHLBI): Respiratory Distress Syndrome, Newborn trials

The registry lists 10 Respiratory Distress Syndrome, Newborn studies with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor. 0 are open to participants now and 1 have results posted.

Phase 2 1Phase 3 9No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Drug Study of Albuterol to Treat Acute Lung InjuryTerminatedNCT00434993Phase 2/3Results posted
• Early Versus Delayed Enteral Feeding to Treat People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN Study)CompletedNCT00883948Phase 3
• Early Versus Delayed Enteral Feeding and Omega-3 Fatty Acid/Antioxidant Supplementation for Treating People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN-Omega Study)TerminatedNCT00609180Phase 3
• Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress SyndromeCompletedNCT00295269Phase 3
• Fluids and Catheters Treatment Trial (FACTT) - ARDS Clinical Research NetworkCompletedNCT00281268Phase 3
• Impact of Surfactant's Availability on NewbornsCompletedNCT00005432
• Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)CompletedNCT00000579Phase 3
• Human Surfactant Treatment of Respiratory Distress Syndrome Bicenter TrialCompletedNCT00000570Phase 3
• High Frequency Ventilation in Premature Infants (HIFI)CompletedNCT00000567Phase 3
• Prevention of Neonatal Respiratory Distress Syndrome With Antenatal Steroid AdministrationCompletedNCT00000563Phase 3